ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
868887170
- Patients with hemophilia A or B
- Patients followed at the Hematology Department of the hospitals included in the study
- Patients without cognitive disorders
- Patients with other congenital coaguopatías
- Patients with more than 2 years without going to review your hospital
- Patients from other provinces of Spain
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Valencia,
Descriptive Information | ||||
---|---|---|---|---|
Brief Title | Adherence to Treatment in Hemophilia | |||
Official Title | Psychosocial Factors and Adherence to Treatment in Patients With Hemophilia. A Multicenter Study | |||
Brief Summary | Psychosocial factors and adherence to treatment in patients with hemophilia. A multicenter study. Multicenter cross sectional study of patients with hemophilia and their families | |||
Detailed Description | Research project whose main objective is to assess adherence and major psychosocial issues affecting patients with hemophilia and their families treated at the Hematology and hemotherapy Services Clinical Hospital Universitario Virgen de la Arrixaca of Murcia and the University Hospital Carlos Haya, Malaga. The data obtained in this project will identify those psychosocial aspects affecting patients and their families about the disease, its evolution and treatment of it. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for hemophilia patients. The main characteristics of the study are:
| |||
Study Type | Observational [Patient Registry] | |||
Study Design | Observational Model: Cohort Time Perspective: Cross-Sectional | |||
Target Follow-Up Duration | 1 Day | |||
Biospecimen | Not Provided | |||
Sampling Method | Non-Probability Sample | |||
Study Population | Patients with haemophilia treated at the Hospital Clínico Universitario Virgen de la Arrixaca de Murcia, and the Hospital Clínico Universitario Carlos Haya (Málaga) | |||
Condition | Haemophilia | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | Patients with haemophilia
Hemophilia patients (children, youth and adults) and parents of children with hemophilia under 18 | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status | Unknown status | |||
Estimated Enrollment | 200 | |||
Original Estimated Enrollment | Same as current | |||
Estimated Study Completion Date | February 2016 | |||
Estimated Primary Completion Date | November 2015 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender |
| |||
Ages | 6 Years to 75 Years (Child, Adult, Older Adult) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Spain | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT02191436 | |||
Other Study ID Numbers | ADHERENCE ADHE ( Other Identifier: UMU ) | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | ANA TORRES-ORTUÑO, Universidad de Murcia | |||
Study Sponsor | ANA TORRES-ORTUÑO | |||
Collaborators | Pfizer | |||
Investigators |
| |||
PRS Account | Universidad de Murcia | |||
Verification Date | September 2015 |